Questionable levels of evidence in new atrial fibrillation guidelines? Reply

Author： Camm A.J. Lip G.Y. De Caterina R. Savelieva I. Atar D. Hohnloser S.H. Hindricks G. Kirchhof P.

ISSN： 1099-5129

Source： EP-Europace, Vol.15, Iss.3, 2013-03, pp. : 461-462

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Questionable levels of evidence in new atrial fibrillation guidelines?

By Van Brabandt Hans Neyt Mattias Devos Carl

EP-Europace, Vol. 15, Iss. 3, 2013-03 ,pp. : 461-461

Oxford University Press

Access to resources Recommend Favorite

Real‐world variability in dabigatran levels in patients with atrial fibrillation: reply

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 6, 2015-06 ,pp. : 1168-1169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Colchicine for Postoperative Atrial Fibrillation Prevention: Is Its Efficacy Questionable?

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 2, 2015-02 ,pp. : 239-240

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapy for atrial fibrillation: new challenges

By Shantsila Eduard Watson Timothy Lip Gregory YH

Therapy, Vol. 3, Iss. 4, 2006-07 ,pp. : 445-448

Future Medicine

Access to resources Recommend Favorite

New antiarrhythmic agents for atrial fibrillation

By Choudhury Anirban Lip Gregory YH

Therapy, Vol. 1, Iss. 1, 2004-09 ,pp. : 111-121

Future Medicine

Access to resources Recommend Favorite